Anticoagulation Europe. (n.d.). http://www.anticoagulationeurope.org/
Atrial fibrillation: management: Guidance and guidelines. (2014). NICE. https://www.nice.org.uk/guidance/cg180
British Society for Haematology. (n.d.). http://www.b-s-h.org.uk/
CLOT UK. (n.d.). http://www.clotuk.com/
England, J. M., Hyde, K., Lewis, S. M., Mackie, I. J., Rowan, R. M., Bain, B. J., Matutes, E. M., Murphy, M. F., Reilly, J. T., Shinton, K., Stephens, A., Wood, J. K., Colvin, B. T., Machin, S. J., Baglin, T., Barrowcliffe, T. W., Greaves, M., Ludlam, C. A., Preston, F. E., … Walker, I. D. (2013). Guidelines for near patient testing: haematology. International Journal of Laboratory Hematology, 17(4), 301–310. https://doi.org/10.1111/j.1365-2257.1995.tb01269.x
Fitzmaurice, D. A., Hobbs, F. D. R., Jowett, S., Mant, J., Murray, E. T., Holder, R., Raftery, J. P., Bryan, S., Davies, M., Lip, G. Y. H., & Allan, T. F. (2007). Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial. BMJ, 335(7616), 383–383. https://doi.org/10.1136/bmj.39280.660567.55
Fitzmaurice, D. A., & Machin, S. J. (2001). Recommendations for patients undertaking self management of oral anticoagulation. BMJ, 323(7319), 985–989. https://doi.org/10.1136/bmj.323.7319.985
Fitzmaurice, D. A., & Murray, E. T. (Eds.). (2013). Oral anticoagulation management and stroke prevention (4th edition). Hayward Medical Communications.
Heneghan, C., Ward, A., Perera, R., Bankhead, C., Fuller, A., Stevens, R., Bradford, K., Tyndel, S., Alonso-Coello, P., Ansell, J., Beyth, R., Bernardo, A., Christensen, T. D., Cromheecke, M., Edson, R. G., Fitzmaurice, D., Gadisseur, A. P., Garcia-Alamino, J. M., Gardiner, C., … Zittermann, A. (2012). Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data. The Lancet, 379(9813), 322–334. https://doi.org/10.1016/S0140-6736(11)61294-4
Jennings, I., Kitchen, D., Keeling, D., Fitzmaurice, D., & Heneghan, C. (2014). Patient self-testing and self-management of oral anticoagulation with vitamin K antagonists: guidance from the British Committee for Standards in Haematology. British Journal of Haematology, 167(5), 600–607. https://doi.org/10.1111/bjh.13070
Keeling, D., Baglin, T., Tait, C., Watson, H., Perry, D., Baglin, C., Kitchen, S., & Makris, M. (2011). Guidelines on oral anticoagulation with warfarin - fourth edition. British Journal of Haematology, 154(3), 311–324. https://doi.org/10.1111/j.1365-2141.2011.08753.x
Mant, J., Hobbs, F. D. R., Fletcher, K., Roalfe, A., Fitzmaurice, D., Lip, G. Y. H., & Murray, E. (2007). Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. The Lancet, 370(9586), 493–503. https://doi.org/10.1016/S0140-6736(07)61233-1
National Patient Safety Agency. (n.d.). http://www.npsa.nhs.uk/
NHS Purchasing and Supply Agency. (n.d.). Buyers guide: point of care coagulometers for monitoring oral anticoagulation. Centre for Evidence Based Purchasing. http://nhscep.useconnect.co.uk/ShowDocument.ashx?id=58&i=true
NICE | The National Institute for Health and Care Excellence. (n.d.). NICE. https://www.nice.org.uk/